BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 38301873)

  • 21. Affinity Chromatography-Based Assays for the Screening of Potential Ligands Selective for G-Quadruplex Structures.
    Platella C; Napolitano E; Riccardi C; Musumeci D; Montesarchio D
    ChemistryOpen; 2022 May; 11(5):e202200090. PubMed ID: 35608081
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phenanthroline polyazamacrocycles as G-quadruplex DNA binders.
    Carvalho J; Quintela T; Gueddouda NM; Bourdoncle A; Mergny JL; Salgado GF; Queiroz JA; Cruz C
    Org Biomol Chem; 2018 Apr; 16(15):2776-2786. PubMed ID: 29611599
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimization of G-Quadruplex Ligands through a SAR Study Combining Parallel Synthesis and Screening of Cationic Bis(acylhydrazones).
    Reznichenko O; Leclercq D; Franco Pinto J; Mouawad L; Gabelica V; Granzhan A
    Chemistry; 2023 Jan; 29(4):e202202427. PubMed ID: 36286608
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent Update on Targeting
    Chaudhuri R; Bhattacharya S; Dash J; Bhattacharya S
    J Med Chem; 2021 Jan; 64(1):42-70. PubMed ID: 33355454
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interface of G-quadruplex with both stabilizing and destabilizing ligands for targeting various diseases.
    Chaudhary S; Kumar M; Kaushik M
    Int J Biol Macromol; 2022 Oct; 219():414-427. PubMed ID: 35940429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structurally diverse G-quadruplexes as the noncanonical nucleic acid drug target for live cell imaging and antibacterial study.
    Zheng BX; Yu J; Long W; Chan KH; Leung AS; Wong WL
    Chem Commun (Camb); 2023 Feb; 59(11):1415-1433. PubMed ID: 36636928
    [TBL] [Abstract][Full Text] [Related]  

  • 27. G-quadruplex structures in the human genome as novel therapeutic targets.
    Bidzinska J; Cimino-Reale G; Zaffaroni N; Folini M
    Molecules; 2013 Oct; 18(10):12368-95. PubMed ID: 24108400
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Promise of G-Quadruplex Structure Binding Ligands as Epigenetic Modifiers with Anti-Cancer Effects.
    Sengupta A; Ganguly A; Chowdhury S
    Molecules; 2019 Feb; 24(3):. PubMed ID: 30736345
    [TBL] [Abstract][Full Text] [Related]  

  • 29. G-Quadruplex-Based Fluorescent Turn-On Ligands and Aptamers: From Development to Applications.
    Umar MI; Ji D; Chan CY; Kwok CK
    Molecules; 2019 Jun; 24(13):. PubMed ID: 31262059
    [TBL] [Abstract][Full Text] [Related]  

  • 30. G-quadruplexes: a promising target for cancer therapy.
    Kosiol N; Juranek S; Brossart P; Heine A; Paeschke K
    Mol Cancer; 2021 Feb; 20(1):40. PubMed ID: 33632214
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interaction of G-quadruplexes with nonintercalating duplex-DNA minor groove binding ligands.
    Jain AK; Bhattacharya S
    Bioconjug Chem; 2011 Dec; 22(12):2355-68. PubMed ID: 22074555
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human telomeric G-quadruplex: the current status of telomeric G-quadruplexes as therapeutic targets in human cancer.
    Neidle S
    FEBS J; 2010 Mar; 277(5):1118-25. PubMed ID: 19951354
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Minimalistic Coumarin Turn-On Probe for Selective Recognition of Parallel G-Quadruplex DNA Structures.
    Deiana M; Obi I; Andreasson M; Tamilselvi S; Chand K; Chorell E; Sabouri N
    ACS Chem Biol; 2021 Aug; 16(8):1365-1376. PubMed ID: 34328300
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insights from Binding on Quadruplex Selective Carbazole Ligands.
    Müller D; Saha P; Panda D; Dash J; Schwalbe H
    Chemistry; 2021 Sep; 27(50):12726-12736. PubMed ID: 34138492
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disentangling the Structure-Activity Relationships of Naphthalene Diimides as Anticancer G-Quadruplex-Targeting Drugs.
    Platella C; Napolitano E; Riccardi C; Musumeci D; Montesarchio D
    J Med Chem; 2021 Apr; 64(7):3578-3603. PubMed ID: 33751881
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Fluorescent Anti-Cancer Agent, 3,6-bis(1-methyl-4-vinylpyridinium) Carbazole Diiodide, Stains G-Quadruplexes in Cells and Inhibits Tumor Growth.
    Tse TY; Chang CC; Lin JJ; Chang TC
    Curr Top Med Chem; 2015; 15(19):1964-70. PubMed ID: 25980413
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [G-quadruplex ligands: mechanisms of anticancer action and target binding].
    Il'inskiĭ NS; Varizhuk AM; Beniaminov AD; Puzanov MA; Shchelkina AK; Kaliuzhnyĭ DN
    Mol Biol (Mosk); 2014; 48(6):891-907. PubMed ID: 25845230
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Template-Assembled Synthetic G-Quartets (TASQs): multiTASQing Molecular Tools for Investigating DNA and RNA G-Quadruplex Biology.
    Monchaud D
    Acc Chem Res; 2023 Feb; 56(3):350-362. PubMed ID: 36662540
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Naphthalene Diimides as Multimodal G-Quadruplex-Selective Ligands.
    Pirota V; Nadai M; Doria F; Richter SN
    Molecules; 2019 Jan; 24(3):. PubMed ID: 30682828
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ligand-induced conformational preorganization of loops of c-MYC G-quadruplex DNA and its implications in structure-specific drug design.
    Harikrishna S; Kotaru S; Pradeepkumar PI
    Mol Biosyst; 2017 Jul; 13(8):1458-1468. PubMed ID: 28650023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.